NEW YORK (GenomeWeb News) – Agilent said after the close of the market on Wednesday that its Fiscal Year 2014 second quarter revenues were flat year over year, while its Life Sciences and Diagnostic revenues increased 1 percent.

For the three months ended April 30, Agilent reported total revenues of $1.73 billion, unchanged from a year ago and even with the consensus analyst estimate. Orders in the quarter were up to $1.81 billion from $1.69 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.